Athyrium Capital Management, LP
Q3 2023 13F Holdings
- Locationnew york, NY
- Num holdings
6
- Value ($000)
$113,555
- Date Filed11/14/2023
- Form type13F-HR
- CIK0001728001
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2023 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
OMER 5.25 02/15/26 Omeros Corp | NOTE 5.250% 2/1 | 682143AG7 | $44.64 M | 39 % | 72,979,000 | ||
BIOR 7.25 12/01/25 Biora Inc. | NOTE 7.250% 12/0 | 74319FAB3 | $27.96 M | 25 % | 53,500,000 | ||
BIOR Biora Inc. | COM NEW | 74319F305 | $23.72 M | 21 % | 10,929,762 | ||
OMER 6.25 11/15/23 Omeros Corp | NOTE 6.250%11/1 | 682143AE2 | $11.26 M | 10 % | 11,005,000 | ||
PBYI PUMA BIOTECHNOLOGY INC | COM | 74587V107 | $4.71 M | 4 % | 1,792,114 | ||
RVL PHARMACEUTICALS PLC | SHS | G6S41R101 | $1.26 M | 1 % | 14,600,444 |
Rows Per Page
10
- 10
- 50
- 100